Catalog Home Page

Misuse of "study drugs:" Prevalence, consequences, and implications for policy

Sussman, S., Pentz, M., Spruijt-Metz, D. and Miller, T. (2006) Misuse of "study drugs:" Prevalence, consequences, and implications for policy. Substance Abuse Treatment, Prevention, and Policy, 1 (1).

[img]
Preview
PDF - Published Version
Download (246kB) | Preview
Free to read: https://doi.org/10.1186/1747-597X-1-15
*No subscription required

Abstract

Background
Non-medical/illegal use of prescription stimulants popularly have been referred to as "study drugs". This paper discusses the current prevalence and consequences of misuse of these drugs and implications of this information for drug policy.

Results
Study drugs are being misused annually by approximately 4% of older teens and emerging adults. Yet, there are numerous consequences of misuse of prescription stimulants including addiction, negative reactions to high dosages, and medical complications. Policy implications include continuing to limit access to study drugs, finding more safe prescription drug alternatives, interdiction, and public education.

Conclusion
Much more work is needed on prescription stimulant misuse assessment, identifying the extent of the social and economic costs of misuse, monitoring and reducing access, and developing prevention and cessation education efforts.

Publication Type: Journal Article
Publisher: BioMed Central
Copyright: © 2006 Sussman et al
URI: http://researchrepository.murdoch.edu.au/id/eprint/40284
Item Control Page Item Control Page

Downloads

Downloads per month over past year